Micrima Ltd.
Micrima is redefining breast awareness through objective measurement and monitoring of breast tissue.
Our radiation-free, non-invasive technology enables repeatable assessment of breast density and tissue characteristics across all adult women. Mi~Scan® allows clinicians and women to establish an individual baseline and track changes over time, including differences between breasts and between assessments.
Mi~Score® integrates this data with established clinical risk models to provide a personalised risk profile, supporting risk stratification and pathway discussions.
Designed to complement existing screening pathways, Micrima enables breast awareness that can be measured, monitored and managed, supporting more informed clinical decisions.
Pharmaceutical companies have solely provided sponsorship for the ABS Conference 2026 through the purchase of exhibition space and/ or sponsored symposia and have had no further input into the arrangements or programme for the event. See the list of sponsors.
